u/isabela_nilsen

Disagree but this is the good kind of wrong — it is specific enough to be checked.

Disagree. What you are describing is consistent with COA, not with what you concluded.

area% and mass% are not the same and this whole post conflates them

Which trial arm and what was the n?

rodent dual agonist is investigation only

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

two labs, two different baselines, two different purity numbers, both honest

no doxxing, company registration is fine, individuals are not

the detector wavelength matters more than people think

the batch number or it did not happen

Same experience. Week 37 and it simply stopped. I know that is not useful information but it is what happened.

Detection wavelength? HPLC and that changes at different wavelengths.

the half-life is gastric emptying, affects steady state timing

Yeah, the fatigue hit on day 12 for me too, not day 1.

related substances are where the story lives, not the main peak

do not generalise from tirzepatide

Metadata check caught a COA that was created in a browser four months after the analysis date.

Disagree on that part. 97.9% and 97.6% on the same vial is normal.

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

Came off after 84 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.

Yeah, data logger is the only acceptable proof.